Global Biologics Contract Development and Manufacturing Organization(CDMO) Market 2019 by Company, Regions, Type and Application, Forecast to 2024


  • Scope of the Report:

    The global Biologics Contract Development and Manufacturing Organization(CDMO) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Contract Development and Manufacturing Organization(CDMO).

    Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

    This report studies the Biologics Contract Development and Manufacturing Organization(CDMO) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Contract Development and Manufacturing Organization(CDMO) market by product type and applications/end industries.


    Market Segment by Companies, this report covers

    Lonza

    Wuxi Biologics

    Thermo Fisher Scientific

    Hansen

    Catalent

    Boehringer Ingelheim BioXcellence

    AGC Biologics

    Samsung BioLogics


    Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


    Market Segment by Type, covers

    Biologics Contract Development Services

    Biologics Contract Manufacturing Services


    Market Segment by Applications, can be divided into

    Big Pharma

    Small Pharma

    Generic Pharma

    Other

     

  • Table of Contents

    1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Overview

    1.1 Product Overview and Scope of Biologics Contract Development and Manufacturing Organization(CDMO)

    1.2 Classification of Biologics Contract Development and Manufacturing Organization(CDMO) by Types

    1.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Comparison by Types (2019-2024)

    1.2.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Types in 2018

    1.2.3 Biologics Contract Development Services

    1.2.4 Biologics Contract Manufacturing Services

    1.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market by Application

    1.3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Market Share Comparison by Applications (2014-2024)

    1.3.2 Big Pharma

    1.3.3 Small Pharma

    1.3.4 Generic Pharma

    1.3.5 Other

    1.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market by Regions

    1.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (Million USD) Comparison by Regions (2014-2024)

    1.4.1 North America (USA, Canada and Mexico) Biologics Contract Development and Manufacturing Organization(CDMO) Status and Prospect (2014-2024)

    1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Contract Development and Manufacturing Organization(CDMO) Status and Prospect (2014-2024)

    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Contract Development and Manufacturing Organization(CDMO) Status and Prospect (2014-2024)

    1.4.4 South America (Brazil, Argentina, Colombia) Biologics Contract Development and Manufacturing Organization(CDMO) Status and Prospect (2014-2024)

    1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Contract Development and Manufacturing Organization(CDMO) Status and Prospect (2014-2024)

    1.5 Global Market Size of Biologics Contract Development and Manufacturing Organization(CDMO) (2014-2024)

    2 Company Profiles

    2.1 Lonza

    2.1.1 Business Overview

    2.1.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.1.2.1 Product A

    2.1.2.2 Product B

    2.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.2 Wuxi Biologics

    2.2.1 Business Overview

    2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.2.2.1 Product A

    2.2.2.2 Product B

    2.2.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.3 Thermo Fisher Scientific

    2.3.1 Business Overview

    2.3.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.3.2.1 Product A

    2.3.2.2 Product B

    2.3.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.4 Hansen

    2.4.1 Business Overview

    2.4.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.4.2.1 Product A

    2.4.2.2 Product B

    2.4.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.5 Catalent

    2.5.1 Business Overview

    2.5.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.5.2.1 Product A

    2.5.2.2 Product B

    2.5.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.6 Boehringer Ingelheim BioXcellence

    2.6.1 Business Overview

    2.6.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.6.2.1 Product A

    2.6.2.2 Product B

    2.6.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.7 AGC Biologics

    2.7.1 Business Overview

    2.7.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.7.2.1 Product A

    2.7.2.2 Product B

    2.7.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    2.8 Samsung BioLogics

    2.8.1 Business Overview

    2.8.2 Biologics Contract Development and Manufacturing Organization(CDMO) Type and Applications

    2.8.2.1 Product A

    2.8.2.2 Product B

    2.8.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Competition, by Players

    3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Share by Players (2014-2019)

    3.2 Market Concentration Rate

    3.2.1 Top 5 Biologics Contract Development and Manufacturing Organization(CDMO) Players Market Share

    3.2.2 Top 10 Biologics Contract Development and Manufacturing Organization(CDMO) Players Market Share

    3.3 Market Competition Trend

    4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions

    4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Market Share by Regions

    4.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    4.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    4.4 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    4.5 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    4.6 Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    5 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries

    5.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries (2014-2019)

    5.2 USA Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    5.3 Canada Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    5.4 Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    6 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries

    6.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries (2014-2019)

    6.2 Germany Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    6.3 UK Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    6.4 France Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    6.5 Russia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    6.6 Italy Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries

    7.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries (2014-2019)

    7.2 China Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    7.3 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    7.4 Korea Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    7.5 India Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    7.6 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    8 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries

    8.1 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries (2014-2019)

    8.2 Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    8.3 Argentina Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    8.4 Colombia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Biologics Contract Development and Manufacturing Organization(CDMO) by Countries

    9.1 Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Countries (2014-2019)

    9.2 Saudi Arabia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    9.3 UAE Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    9.4 Egypt Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    9.5 Nigeria Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    9.6 South Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2014-2019)

    10 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Segment by Type

    10.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Market Share by Type (2014-2019)

    10.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Type (2019-2024)

    10.3 Biologics Contract Development Services Revenue Growth Rate (2014-2024)

    10.4 Biologics Contract Manufacturing Services Revenue Growth Rate (2014-2024)

    11 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Segment by Application

    11.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2014-2019)

    11.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Application (2019-2024)

    11.3 Big Pharma Revenue Growth (2014-2019)

    11.4 Small Pharma Revenue Growth (2014-2019)

    11.5 Generic Pharma Revenue Growth (2014-2019)

    11.6 Other Revenue Growth (2014-2019)

    12 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast (2019-2024)

    12.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast (2019-2024)

    12.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Regions (2019-2024)

    12.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Forecast (2019-2024)

    12.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Forecast (2019-2024)

    12.5 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Forecast (2019-2024)

    12.6 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Forecast (2019-2024)

    12.7 Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

    14 Appendix

    14.1 Methodology

    14.2 Data Source

     

This is a single user license, allowing one specific user access to the product.

This is a 1-10 user licence, allowing up to ten users have access to the product.

This is a site license, allowing all users within a given geographical location of your organisation access to the product.

Need Assistance ?

Our Clients